Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer
-
* Corresponding author: Edison T Liu liue@gis.a-star.edu.sg
1 Genome Institute of Singapore, 60 Biopolis Street, #02-01, Singapore 138672, Republic of Singapore
2 Department of Microbiology and Molecular Biology, Brigham Young University, 753 WIDB, Provo, UT 84602, USA
3 Center for Biotechnology, Karolinska Institute, Hälsovägen 7-9, 141 57 Huddinge, Novum, Sweden
4 Radiumhemmet, Karolinska Institute and University Hospital, S-171 76 Stockholm, Sweden
5 Department of Biosciences and Nutrition, Karolinska Institute, Hälsovägen 7-9, 141 57 Huddinge, Novum, Sweden
Breast Cancer Research 2007, 9:R25 doi:10.1186/bcr1667
Published: 10 April 2007Additional files
Additional file 1:
Cell line estrogen receptor beta overexpression and E2 treatment microarray data with log2-transformed fold-change data as compared to the untreated uninduced control at each time point.
Format: XLS Size: 7.9MB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 2:
Uppsala patient information, including estrogen receptor (ER) beta transcript levels and ER alpha protein levels.
Format: XLS Size: 20KB Download file
This file can be viewed with: Microsoft Excel Viewer
Additional file 3:
Gene ontology annotations (2002 version) made by Compugen USA, Inc. (Jamesburg, NJ, USA) for probes represented on the microarrays used for the cell line study.
Format: XLS Size: 2MB Download file
This file can be viewed with: Microsoft Excel Viewer
